Can Sodium Bicarbonate Lower Creatinine?

The clinical truth about sodium bicarbonate and creatinine. Learn how medical use stabilizes kidney function and slows disease progression.

Sodium bicarbonate does not directly lower creatinine in the way a drug might target a specific lab value. What it can do, in people with chronic kidney disease and metabolic acidosis, is slow the decline in kidney function, which in turn keeps creatinine from climbing as fast. A pooled analysis of clinical trials found that oral sodium bicarbonate preserved kidney filtration rates and reduced the risk of progressing to end-stage kidney failure by roughly half. But not every study agrees, and the distinction between preserving kidney function over months and producing a quick drop in a creatinine reading matters more than most online discussions acknowledge.

Why Low Bicarbonate Damages the Kidneys

Healthy kidneys maintain your blood’s acid-base balance by excreting acid and regenerating bicarbonate. As kidney function declines, that capacity shrinks, and acid builds up in the blood. This condition, metabolic acidosis, is common in moderate to advanced chronic kidney disease. What makes it dangerous is that the kidneys’ own attempts to compensate end up causing further harm. To excrete more acid, the remaining nephrons ramp up production of hormones like angiotensin II, aldosterone, and endothelin-1. In the short term, those hormones help dump acid. Over months and years, their chronic overproduction drives inflammation, scarring, and progressive loss of nephron function.

At the same time, increased ammonia production per nephron activates complement pathways that deposit damaging proteins in the tissue surrounding the kidney tubules. The result is a vicious cycle: acidosis triggers compensatory mechanisms that cause fibrosis, which destroys more nephrons, which worsens the acidosis. The logic behind sodium bicarbonate therapy is straightforward: if you supply bicarbonate from outside, the kidneys don’t have to work as hard to restore acid-base balance, and those damaging hormonal responses quiet down.

What Clinical Trials Actually Show

A systematic review and meta-analysis pooling data from multiple trials found that oral sodium bicarbonate slowed the decline in estimated glomerular filtration rate (eGFR, the standard measure of kidney function) by about 4.4 mL/min compared to control groups. It also raised serum bicarbonate levels by roughly 2.4 mEq/L and reduced a key marker of kidney damage, the urinary albumin-to-creatinine ratio, by about 31 mg/g. In practical terms, a 4.4-point preservation in eGFR is meaningful: it can represent years of slower progression toward dialysis.

But one of the larger and more rigorously designed trials tells a different story. A multicenter, placebo-controlled randomized trial in patients with stage 3 and 4 CKD found no significant differences in eGFR, blood pressure, weight, or serious side effects between the sodium bicarbonate group and the placebo group. This trial has received a lot of attention precisely because it used a placebo, which many earlier studies did not. Several of the positive studies compared bicarbonate to no treatment at all, and the act of taking any additional pill or supplement (the placebo effect, plus closer follow-up) can skew results. The conflicting evidence means you should be cautious about expecting a dramatic creatinine drop from sodium bicarbonate. The truth likely sits somewhere in between: a real but modest benefit in the right patients, not a universal kidney rescue.

Can Bicarbonate Keep You Off Dialysis

Even if the effect on creatinine itself is debated, the effect on hard clinical endpoints has been more encouraging. An early single-center study of patients with advanced CKD found that those given bicarbonate supplements were far less likely to progress to end-stage renal disease: about 6.5% in the bicarbonate group versus 33% in the control group. A larger Italian study, the UBI trial, aimed for a target serum bicarbonate of 24 to 28 mmol/L in the treatment group and found that patients receiving sodium bicarbonate had about a 50% lower risk of starting dialysis during follow-up.

A broader meta-analysis that synthesized results across available trials similarly concluded that sodium bicarbonate slowed kidney function decline and cut the risk of end-stage kidney failure roughly in half, though the authors rated the overall certainty of evidence as low. That “low certainty” label is important. It means the existing studies, taken together, have enough limitations (small samples, lack of blinding, inconsistent designs) that the pooled numbers could shift as larger trials report results. The direction of the evidence leans positive, but the strength of that lean is moderate at best.

Acute Kidney Injury and Contrast Dye

The question of whether bicarbonate can lower creatinine also comes up in acute settings, particularly when patients receive iodinated contrast dye for CT scans or cardiac catheterization procedures. Contrast dye can injure the kidneys, causing a spike in creatinine within 24 to 72 hours. In patients already at elevated risk, one randomized trial found that hydration with sodium bicarbonate instead of plain saline led to a decrease in creatinine at 24 and 48 hours, and the rate of contrast-induced kidney injury dropped from about 9% with saline to about 1.4% with bicarbonate. A systematic review of several prospective trials supported this finding, showing a roughly one-third reduction in the risk of contrast-induced acute kidney injury with bicarbonate-based hydration.

This is one scenario where bicarbonate can genuinely produce a measurable creatinine change in the short term, not by improving baseline kidney function but by preventing an acute injury that would otherwise raise creatinine. Hospital protocols vary on whether they use bicarbonate or saline for pre-procedure hydration, and some larger subsequent trials have questioned whether the benefit is as robust as earlier studies suggested. Still, it remains a common strategy in patients considered high-risk.

Rhabdomyolysis and the Limits of Alkalinization

Another acute context is rhabdomyolysis, where damaged muscle releases large quantities of myoglobin into the bloodstream. Myoglobin can clog and injure kidney tubules, and the idea behind bicarbonate therapy here is that alkalinizing the urine prevents myoglobin from precipitating in the tubules, reducing direct pigment injury and oxidative damage. The concept is plausible and widely taught, but the clinical evidence is underwhelming. A study of patients with post-traumatic rhabdomyolysis who had significantly elevated creatine kinase levels found no difference in rates of kidney failure, need for dialysis, or mortality between those who received bicarbonate plus mannitol and those who did not. Despite this, many hospitals continue to use bicarbonate in rhabdomyolysis protocols, largely because aggressive fluid resuscitation (the main intervention) is clearly beneficial and bicarbonate is often included as a component. The evidence for its independent contribution remains thin.

The Dangers of Self-Medicating with Baking Soda

If you have read this far and are thinking about buying a box of baking soda at the grocery store, here is where the article takes a turn. Unsupervised ingestion of sodium bicarbonate carries real risks. Case reports document severe metabolic alkalosis (the blood becoming too basic, which is just as dangerous as it being too acidic), dangerously low potassium levels, high sodium levels, and even respiratory depression from baking soda overdose. Beyond the acute toxicity, chronic overuse can cause high blood pressure, fluid overload, and disruptions to the body’s renin system that regulates blood pressure and fluid balance.

The clinical trials that showed benefit used carefully titrated doses, monitored blood levels, and adjusted treatment to hit specific serum bicarbonate targets (typically 24 to 28 mmol/L). That is a very different proposition from spooning baking soda into water at home. People with CKD are already at elevated risk for fluid retention and electrolyte imbalances, meaning unmonitored sodium bicarbonate use could create the very problems it is meant to prevent. If you have kidney disease and low bicarbonate levels, this is a conversation to have with a nephrologist who can prescribe the right dose and monitor your labs, not a home experiment.

Dietary Ways to Fight Acidosis Without the Sodium Load

One of the practical downsides of sodium bicarbonate is that it adds sodium to your diet, and many people with CKD are already advised to limit sodium to protect their blood pressure and reduce fluid retention. This has led researchers to explore whether dietary changes can accomplish some of the same acid-base correction without the sodium burden. Diets high in meat and refined grains increase the body’s acid load, while diets rich in fruits and vegetables can help neutralize that acidity. Some small clinical studies have found that adding servings of fruits and vegetables to the diets of CKD patients improved their serum bicarbonate levels to a degree comparable to oral bicarbonate supplements, and without the extra sodium.

Potassium citrate is another alternative that nephrologists sometimes consider. Both potassium citrate and sodium citrate effectively raise urinary pH and boost citrate excretion, but potassium citrate has the added benefit of significantly lowering urinary calcium, which sodium-based alkali therapies do not. The catch is that potassium citrate raises potassium levels, and people with advanced CKD often struggle with high potassium already. There is no one-size-fits-all alkali therapy, which is part of why this area of nephrology remains active and unsettled.

What Happens in Healthy Kidneys

Most of the evidence discussed above applies to people who already have compromised kidney function and measurable acidosis. If you have healthy kidneys and a normal creatinine level, sodium bicarbonate will not lower your creatinine further. Your kidneys are already maintaining acid-base balance efficiently, and there is no acidosis-driven damage to correct. A study of sodium bicarbonate supplementation in the context of high-intensity exercise found that while it did shift blood pH and some blood markers during recovery, it did not produce significant changes in creatinine compared to a placebo.

This reinforces the central point: sodium bicarbonate’s ability to influence creatinine depends almost entirely on whether there is underlying acidosis and kidney damage to address. In the absence of disease, it is simply a surplus buffer that your kidneys will excrete without fanfare. The people most likely to see a meaningful difference are those with moderate to advanced CKD, documented metabolic acidosis, and a nephrologist guiding their treatment. For everyone else, the creatinine on your lab report is going to look the same whether you take baking soda or not.

Emerging Research on the Gut-Kidney Connection

An interesting branch of newer research has started exploring how sodium bicarbonate might affect the kidneys indirectly, through the gut. An animal study in mice with kidney stone-induced kidney injury found that oral sodium bicarbonate not only reduced crystal deposits in the kidneys and restored kidney function markers, but also improved the intestinal barrier by increasing the expression of proteins that keep gut cells tightly connected. It also remodeled the composition of the gut microbiome and reduced intestinal inflammation. The idea that a leaky gut allows bacterial toxins to reach the kidneys and worsen damage is gaining traction in nephrology, and if bicarbonate can shore up that barrier, it would represent a mechanism of action entirely separate from the acid-base story described above. This is still early-stage work in animals, so it is far too soon to call it clinically relevant. But it hints at layers of complexity that the simple “neutralize the acid” explanation does not capture, and it is the kind of finding that may reshape how nephrologists think about bicarbonate therapy in the coming decade.